| Room 204AB (Washington DC Convention Center) | |||
| Paper Presentations: Molecular Approaches to Pain and Pain Treatment | |||
| 600 | Systemic morphine administration reduces local cytokine expression after incision David J. Clark, MD/PhD, Deyong Liang, Yanli Qiao, MD, Xiangqi Li, MD, Xiaoyou Shi, MD, Martin Angst, MD, David Yeomans, PhD | ||
| 603 | Postsynaptic spinal mu opioid receptor-expressing neurons are required for morphine anti-hyperalgesia Robert H. Kline IV, BS, Ronald G. Wiley, MD, PhD | ||
| 609 | Resequencing of the pain candidate gene, GCH1, to identify novel variants potentially responsible for changes in function Carly L. Kiselycznyk, Inna Belfer, MD, PhD, Zhifeng Zhou, PhD, Jemiel Nejim, Bikash Mishra, MD, Antonella Bollettino, David Goldman, MD, Mitchell B. Max, MD | ||
| 616 | Genetic polymorphisms in GTP-cyclohydrolase gene (GCH1) do not affect acute experimental and clinical pain in humans Hyungsuk Kim, DDS, PhD, Hyewon Lee, Raymond Dionne | ||
| 650 | Small interfering RNAs-(siRNAs) that target expression of the NMDAR1 subunit gene in the spinal cord dorsal horn prevent inflammatory allodynia Sandra M. Garraway, PhD, Qinghao Xu, BS, Charles E. Inturrisi, PhD | ||
| 743 | A human neuronal cell line to treat neuropathic pain Stacey Quintero Wolfe, MD, Ingrid Menendez, Miguel Martinez, BA, Mary J. Eaton, PhD | ||
[Recording]
Return to the Schedule of Events
See more of Papers and Posters